Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael

Showing results (1061-1070 of 1,257) with videos related to

Pageof 126
Sort By:
American Heart Journal|April 17, 2025
Association of testosterone-induced increase in neutrophil and monocyte counts with thromboembolic events: The TRAVERSE trialThiago Gagliano-Jucá, Karol M Pencina, Yili V Shang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 2, 2015
Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trialsJennifer Yu, Roxana Mehran, Tim Clayton, et al.
European Heart Journal|April 13, 2006
Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trialPadma Kaul, Wei-Ching Chang, A Michael Lincoff, et al.
Nature Communications|September 28, 2016
Megacity pumping and preferential flow threaten groundwater qualityMahfuzur R Khan, Mohammad Koneshloo, Peter S K Knappett, et al.
Journal of the American College of Cardiology|June 21, 2005
Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trialHitinder S Gurm, Ian J Sarembock, Dean J Kereiakes, et al.
The Journal of Nutrition|June 24, 2011
Diet, environmental factors, and lifestyle underlie the high prevalence of vitamin D deficiency in healthy adults in Scotland, and supplementation reduces the proportion that are severely deficientLina Zgaga, Evropi Theodoratou, Susan M Farrington, et al.
The American Journal of Cardiology|December 28, 2014
Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarctionJosephine Warren, Roxana Mehran, Jennifer Yu, et al.
Chest|June 6, 2026
Cutting waste in bronchoscopy - a multicenter observational study in the German healthcare systemA Seeger, L Welsch, S Kim, et al.
JAMA Cardiology|December 23, 2025
Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical TrialStephen J Nicholls, Donna H Ryan, John Deanfield, et al.
American Heart Journal|September 11, 2013
Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trialA Michael Lincoff, Jean-Claude Tardif, Bruce Neal, et al.
Pageof 126

Showing results (1061-1070 of 1,257) with videos related to

Sort By:
Pageof 126
American Heart Journal|April 17, 2025
Association of testosterone-induced increase in neutrophil and monocyte counts with thromboembolic events: The TRAVERSE trialThiago Gagliano-Jucá, Karol M Pencina, Yili V Shang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 2, 2015
Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trialsJennifer Yu, Roxana Mehran, Tim Clayton, et al.
European Heart Journal|April 13, 2006
Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trialPadma Kaul, Wei-Ching Chang, A Michael Lincoff, et al.
Nature Communications|September 28, 2016
Megacity pumping and preferential flow threaten groundwater qualityMahfuzur R Khan, Mohammad Koneshloo, Peter S K Knappett, et al.
Journal of the American College of Cardiology|June 21, 2005
Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trialHitinder S Gurm, Ian J Sarembock, Dean J Kereiakes, et al.
The Journal of Nutrition|June 24, 2011
Diet, environmental factors, and lifestyle underlie the high prevalence of vitamin D deficiency in healthy adults in Scotland, and supplementation reduces the proportion that are severely deficientLina Zgaga, Evropi Theodoratou, Susan M Farrington, et al.
The American Journal of Cardiology|December 28, 2014
Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarctionJosephine Warren, Roxana Mehran, Jennifer Yu, et al.
Chest|June 6, 2026
Cutting waste in bronchoscopy - a multicenter observational study in the German healthcare systemA Seeger, L Welsch, S Kim, et al.
JAMA Cardiology|December 23, 2025
Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical TrialStephen J Nicholls, Donna H Ryan, John Deanfield, et al.
American Heart Journal|September 11, 2013
Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trialA Michael Lincoff, Jean-Claude Tardif, Bruce Neal, et al.
Pageof 126